Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$5.77 1.05%
Market Cap
$18.5M
Price Target
Refer to Report
Volume
29.6K
52wk Range
$3.935 - $20
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.